American Century Companies’s CG Oncology CGON Stock Holding History
Bought
Maintained
Sold
Other funds holding CGON
RI
DC
TCM
VPM
VCM
American Century Companies's CGON Position: Q1 2026 in Review
American Century Companies reduced its CG Oncology (CGON) stake by 96% in Q1 2026, selling an estimated $6.78M and leaving 4,907 shares worth $332K. The position accounts for ﹤0.01% of the portfolio, ranked #2614.
American Century Companies first reported a position in CGON in Q2 2025 and has held it in 4 quarters since. The position peaked at $5.17M in Q4 2025. 233 funds tracked by Wall St. Rank hold CGON as of Q1 2026.
- American Century Companies held 4,907 shares of CG Oncology worth $332K as of Q1 2026.
- American Century Companies sold 119,637 CG Oncology shares in Q1 2026, an estimated $6.78M.
- CG Oncology made up ﹤0.01% of American Century Companies's portfolio in Q1 2026, its #2614 holding.
- American Century Companies first reported a position in CG Oncology in Q2 2025 and has held it in 4 quarters since.
- American Century Companies's CG Oncology position peaked at $5.17M in Q4 2025.
- 233 funds tracked by Wall St. Rank held CG Oncology as of Q1 2026.
Based on American Century Companies's 13F filing for Q1 2026, filed 15 May 2026.